|
|
|
| Engineering Reliability In Cell Therapy Manufacturing | White Paper | ElevateBio | A cell therapy manufacturing model built on precision planning, digital execution, lifecycle‑ready CMC systems, and transparent collaboration to achieve high reliability and reduce variability across programs. |
|
|
| The Continuation Of A Journey | Article | Andelyn Biosciences | See how one family managed to get an investigational gene replacement therapy manufactured and approved by the FDA so their daughter could be dosed just 14 months from her diagnosis. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Seema Singh of Daiichi Sankyo represents today’s global regulatory leadership in the biopharmaceutical sector. She reflects what the highest expectations should be for all CDMOs, whether your organization is an exacting Japan Pharma, or a start-up biotech in the U.S. Here are her key actions for creating an optimal outsourcing relationship. | |
|
|
7 Outsourcing Behaviors To Protect Timelines | By Jeffrey S. Buguliskis, Ph.D., deputy chief editor, Outsourced Pharma | Protecting manufacturing timelines in 2026 means converting speed from a hope into a contractual commitment through strategic prepayment, integrated partnerships, and formalized accountability. |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Consistency Engineered For Animal‑Free Bioprocessing | Infographic | Nu-Tek Biosciences | Animal‑free soy‑based materials provide consistent molecular weight profiles, stable mineral levels, and controlled manufacturing to ensure reliable, reproducible bioprocessing performance. |
|
|
| Tailoring Viral Clearance Study Design | White Paper | Minaris | Viral‑clearance studies need phase‑appropriate design, strong virus stocks, modality‑specific risk assessment, and alignment with evolving regulations for reliable safety outcomes. |
|
|
| Revolutionizing Gene Therapy Manufacturing | Webinar | Thermo Fisher Scientific | By integrating perfusion into upstream manufacturing, see how this approach has achieved up to a fivefold increase in productivity, delivering titers that significantly exceed current industry benchmarks. |
|
|
|
| How Integrated Data Systems Enhance Clinical Development | Article | Resilience, LLC. | Delve into how cloud-based systems and unified data platforms are transforming biomanufacturing by enhancing efficiency, ensuring quality, and accelerating the delivery of complex therapies to market. |
|
|
| Translating Stem Cell Programs To GMP | Webinar | Landmark Bio | A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing. |
|
|
|
|
|
|
|
Your All-In AAV, All-The-Time CDMO | Viralgen | Accelerate rAAV gene therapy manufacturing with unmatched speed, expertise, and scale—delivering clinical and commercial supply to help innovators reduce risk and achieve regulatory confidence. |
|
|
Headcount Solutions Without Co-Employment Risk | Eurofins PSS Insourcing Solutions | A strategic managed services model that supplies trained scientific staff onsite to meet operational needs without adding headcount or assuming co-employment risk. |
|
|
|
Cell-Free DNA Technology | Aldevron | Introducing our latest innovation. This enzymatic DNA manufacturing process produces linear DNA (linDNA) templates for in vitro transcription (IVT) of mRNA. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
